<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01811004</url>
  </required_header>
  <id_info>
    <org_study_id>CYN12-GS-HH01</org_study_id>
    <nct_id>NCT01811004</nct_id>
  </id_info>
  <brief_title>Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Purpose of the study is to evaluate the 1440nm Laser Assisted Selective Photothermolysis&#xD;
      vs. Botulinum Toxin or miraDry® Microwave Thermolysis For Treatment of Axillary&#xD;
      Hyperhidrosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Sweating Assessed Using Gravimetry</measure>
    <time_frame>1 month follow up</time_frame>
    <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Sweating Assessed Using Gravimetry</measure>
    <time_frame>3 month follow up</time_frame>
    <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Sweating Assessed Using Gravimetry</measure>
    <time_frame>6 month follow up</time_frame>
    <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Sweating Assessed Using Gravimetry</measure>
    <time_frame>9 month follow up</time_frame>
    <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Hyperhidrosis</condition>
  <arm_group>
    <arm_group_label>Botox®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Botox®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>miraDry®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>miraDry®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nd: YAG laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nd: YAG laser 1440nm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>miraDry</intervention_name>
    <description>miraDry</description>
    <arm_group_label>miraDry®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nd:YAG Laser</intervention_name>
    <description>Nd:YAG 1440 nm Laser</description>
    <arm_group_label>Botox®</arm_group_label>
    <arm_group_label>Nd: YAG laser</arm_group_label>
    <arm_group_label>miraDry®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Botox®</intervention_name>
    <description>Botox®</description>
    <arm_group_label>Botox®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A healthy non-smoking male or female between 18-70 years of age&#xD;
&#xD;
          -  Understand/accept obligation not to receive any other procedures in anatomical areas&#xD;
             exhibiting axillary hyperhidrosis through 3 months prior to treatment&#xD;
&#xD;
          -  Understand and accept the obligation and is logistically able to present for all&#xD;
             scheduled follow-up visits&#xD;
&#xD;
          -  Clinically diagnosed for primary hyperhidrosis of the axilla.&#xD;
&#xD;
          -  A self-assessed Hyperhidrosis Disease Severity Scale (HDSS) score of three (3) or four&#xD;
             (4) a. Gravimetric &gt;50mg/5min in each axilla&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of secondary hyperhidrosis&#xD;
&#xD;
          -  Uncontrolled systemic disease or infection&#xD;
&#xD;
          -  Concurrent use of any hyperhidrosis treatments other than over the counter&#xD;
             antiperspirants or deodorants&#xD;
&#xD;
          -  Receipt of Botox® or Dysport® within the past six months&#xD;
&#xD;
          -  Patients who refuse to stop using over the counter antiperspirants 24 hours prior to&#xD;
             the day of surgery and each of the follow-up visits at 3 months and 6 months that&#xD;
             Minors starch iodine tests may be performed.&#xD;
&#xD;
          -  Patients using or having used within 7 days of baseline visit: cholinomimetic agents,&#xD;
             anticholinergic agents, prescription antiperspirants, any herbal medicine treatments&#xD;
             or any other treatments for hyperhidrosis except OTC antiperspirant or planning to use&#xD;
             such agents during the course of the study.&#xD;
&#xD;
          -  Any previous liposuction/liposculpture or any type of surgery for hyperhidrosis; OR&#xD;
             any other types of treatments for hyperhidrosis in the area to be treated in the past&#xD;
             6 months&#xD;
&#xD;
          -  Has any other medical condition, that, in the investigator's opinion would interfere&#xD;
             with the subject's participation in the study&#xD;
&#xD;
          -  Is susceptible to light induced seizures or history of seizures&#xD;
&#xD;
          -  Has a history of keloid formation&#xD;
&#xD;
          -  Significant cardiovascular disease&#xD;
&#xD;
          -  Bleeding disorders&#xD;
&#xD;
          -  Anti-platelet and anticoagulant medication&#xD;
&#xD;
          -  Sensitivity to lidocaine or epinephrine&#xD;
&#xD;
          -  Pregnancy or planned pregnancy&#xD;
&#xD;
          -  Existing neuromuscular disorders (myasthenia gravis, Eaton-Lambert Syndrome,&#xD;
             amyotrophic lateral sclerosis)&#xD;
&#xD;
          -  Electronic implants&#xD;
&#xD;
          -  Subjects requiring supplemental oxygen&#xD;
&#xD;
          -  Has therapies or medications which may interfere with the treatment (including&#xD;
             medications causing photosensitivity&#xD;
&#xD;
          -  Allergic to Keflex&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sasaki Advanced Aesthetic Medical Center</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2013</study_first_posted>
  <results_first_submitted>October 15, 2020</results_first_submitted>
  <results_first_submitted_qc>December 28, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 22, 2021</results_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperhidrosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Nd: YAG Laser and miraDry</title>
          <description>Nd: YAG laser 1440nm and miraDry&#xD;
For each patient, one axilla was treated with the 1440 nm Diode laser and the opposite axilla was treated with miraDry. The subject is treated with miraDry at day 0, and again at day 90.&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Diode Laser with a Rep Rate of 25 Hz. Total energy around 1500 J per 5cm x 5cm sector.</description>
        </group>
        <group group_id="P2">
          <title>Nd: YAG Laser 1440nm and Botox</title>
          <description>Nd: YAG laser 1440nm and Botox&#xD;
For each patient, one axilla was treated with the 1440 nm Diode laser and the opposite axilla was treated with Botox.&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Diode Laser with a Rep Rate of 25 Hz. Total energy around 1500 J per 5cm x 5cm sector.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nd: YAG Laser- miraDry</title>
          <description>Nd: YAG laser 1440nm&#xD;
miraDry: miraDry</description>
        </group>
        <group group_id="B2">
          <title>Nd: YAG Laser- Botox</title>
          <description>Nd:YAG Laser: Nd:YAG 1440 nm Laser&#xD;
Botox®: Botox®</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race/Ethnicity</title>
              <category_list>
                <category>
                  <title>Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Puerto Rican/Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>African American/Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other (Not Specified)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fitzpatrick Skin Score</title>
          <description>The Fitzpatrick Skin Score is used to determine skin color. It is a numerical system that classifies skin into six types (Type I, Type II, Type III, Type IV, Type V and Type VI) based on the numerical score achieved (ranging from 0 to 36). The lower the score (and skin type number), the fairer the skin. The higher the score (and skin type number), the more deeply pigmented the skin is.&#xD;
The scale comes from this source:&#xD;
Gupta, Sharma. Skin typing: Fitzpatrick grading and others. Clinics in Dermatology. 2019;37(5):430-436. doi:10.1016/j.clindermatol.2019.07.010</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Fitzpatrick Skin Score I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fitzpatrick Skin Score II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fitzpatrick Skin Score III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fitzpatrick Skin Score IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fitzpatrick Skin Score V</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Fitzpatrick Skin Score VI</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Sweating Assessed Using Gravimetry</title>
        <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
        <time_frame>1 month follow up</time_frame>
        <population>One subject in the Botox treatment was a no-show to their scheduled follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>Botox®</title>
            <description>Botox®&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Laser&#xD;
Botox®: Botox®</description>
          </group>
          <group group_id="O2">
            <title>miraDry®</title>
            <description>miraDry®&#xD;
miraDry: miraDry&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Laser</description>
          </group>
          <group group_id="O3">
            <title>Nd: YAG Laser</title>
            <description>Nd: YAG laser 1440nm</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sweating Assessed Using Gravimetry</title>
          <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
          <population>One subject in the Botox treatment was a no-show to their scheduled follow up.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="267.91" spread="432.53"/>
                    <measurement group_id="O2" value="57.36" spread="33.55"/>
                    <measurement group_id="O3" value="155.14" spread="263.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Sweating Assessed Using Gravimetry</title>
        <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
        <time_frame>3 month follow up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Botox®</title>
            <description>Botox®&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Laser&#xD;
Botox®: Botox®</description>
          </group>
          <group group_id="O2">
            <title>miraDry®</title>
            <description>miraDry®&#xD;
miraDry: miraDry&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Laser</description>
          </group>
          <group group_id="O3">
            <title>Nd: YAG Laser</title>
            <description>Nd: YAG laser 1440nm</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sweating Assessed Using Gravimetry</title>
          <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="231.89" spread="407.42"/>
                    <measurement group_id="O2" value="53.59" spread="38.67"/>
                    <measurement group_id="O3" value="22.72" spread="31.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Sweating Assessed Using Gravimetry</title>
        <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
        <time_frame>6 month follow up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Botox®</title>
            <description>Botox®&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Laser&#xD;
Botox®: Botox®</description>
          </group>
          <group group_id="O2">
            <title>miraDry®</title>
            <description>miraDry®&#xD;
miraDry: miraDry&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Laser</description>
          </group>
          <group group_id="O3">
            <title>Nd: YAG Laser</title>
            <description>Nd: YAG laser 1440nm</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sweating Assessed Using Gravimetry</title>
          <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="223.51" spread="380.18"/>
                    <measurement group_id="O2" value="65.93" spread="46.48"/>
                    <measurement group_id="O3" value="39.07" spread="42.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Sweating Assessed Using Gravimetry</title>
        <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
        <time_frame>9 month follow up</time_frame>
        <population>The gravimetric test was not required for the 9 month follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>Botox®</title>
            <description>Botox®&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Laser&#xD;
Botox®: Botox®</description>
          </group>
          <group group_id="O2">
            <title>miraDry®</title>
            <description>miraDry®&#xD;
miraDry: miraDry&#xD;
Nd:YAG Laser: Nd:YAG 1440 nm Laser</description>
          </group>
          <group group_id="O3">
            <title>Nd: YAG Laser</title>
            <description>Nd: YAG laser 1440nm</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sweating Assessed Using Gravimetry</title>
          <description>A gravimetry test was performed to determine the quantity of sweat produced, comparing the post-treatment to the baseline numbers. A pre-weighted filter paper was placed on the armpit, and then weighed afterwards to determine the quantity of sweat produced.</description>
          <population>The gravimetric test was not required for the 9 month follow up.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.49" spread="81.27"/>
                    <measurement group_id="O2" value="67.06" spread="44.3"/>
                    <measurement group_id="O3" value="28.36" spread="37.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Events occurring were collected throughout the study, around 18 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Botox®</title>
          <description>Botox® and Nd:YAG Laser: 1440 nm Laser</description>
        </group>
        <group group_id="E2">
          <title>miraDry®</title>
          <description>miraDry® and Nd:YAG 1440 nm Laser</description>
        </group>
        <group group_id="E3">
          <title>Nd: YAG Laser</title>
          <description>Nd: YAG laser: 1440nm</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Numbness</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Redness</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Bruising</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Itching</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Nodule</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Hardness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI cannot disclose confidential or proprietary information until after it becomes generally known or available to the public.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jamie Trimper</name_or_title>
      <organization>Cynosure</organization>
      <phone>800-886-2966</phone>
      <email>jamie.trimper@cynosure.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

